An open-label, prospective, single-arm study of switching from infliximab to cyclosporine for refractory uveitis in patients with Behçet’s disease in long-term remission

2021 ◽  
Author(s):  
Yasutsugu Ida ◽  
Masaki Takeuchi ◽  
Mami Ishihara ◽  
Etsuko Shibuya ◽  
Takahiro Yamane ◽  
...  
Keyword(s):  
Behçet’S Disease ◽  
Behcet’S Disease ◽  
Behçet's Disease ◽  
Open Label ◽  
Behcet's Disease

Brief Report: Drug-Free Long-Term Remission in Severe Behçet's Disease Following Withdrawal of Successful Anti-Tumor Necrosis Factor Treatment

2017 ◽  
Vol 69 (12) ◽  
pp. 2380-2385 ◽  
Author(s):  
Petros P. Sfikakis ◽  
Aikaterini Arida ◽  
Stylianos Panopoulos ◽  
Kalliopi Fragiadaki ◽  
George Pentazos ◽  
...  
Keyword(s):  
Tumor Necrosis Factor ◽  
Behçet’S Disease ◽  
Tumor Necrosis ◽  
Behcet’S Disease ◽  
Behçet's Disease ◽  
Behcet's Disease ◽  
Drug Free ◽  
Necrosis Factor ◽  
Tumor Necrosis Factor Treatment

scholarly journals Long-term efficacy and safety of anakinra in a patient with Behçet's disease and concomitant tuberculosis infection

2016 ◽  
Vol 56 (2) ◽  
pp. 218-220 ◽  
Author(s):  
Giacomo Emmi ◽  
Elena Silvestri ◽  
Danilo Squatrito ◽  
Antonio Vitale ◽  
Daniela Bacherini ◽  
...  
Keyword(s):  
Behçet’S Disease ◽  
Behcet’S Disease ◽  
Behçet's Disease ◽  
Tuberculosis Infection ◽  
Efficacy And Safety ◽  
Behcet's Disease ◽  
Term Efficacy

Long-term efficacy and safety of golimumab in the treatment of multirefractory Behçet’s disease

2017 ◽  
Vol 36 (9) ◽  
pp. 2063-2069 ◽  
Author(s):  
Antonio Vitale ◽  
Giacomo Emmi ◽  
Giuseppe Lopalco ◽  
Claudia Fabiani ◽  
Stefano Gentileschi ◽  
...  
Keyword(s):  
Behçet’S Disease ◽  
Behcet’S Disease ◽  
Behçet's Disease ◽  
Efficacy And Safety ◽  
Behcet's Disease ◽  
Term Efficacy
Sign in / Sign up

Export Citation Format

Share Document